UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune checkpoint receptors in autoimmunity

Current opinion in immunology, 2023-02, Vol.80, p.102283-102283, Article 102283

2023

Volltextzugriff (PDF)

The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?

Frontiers in immunology, 2024-03, Vol.15, p.1385781-1385781

2024

Volltextzugriff (PDF)

Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods

Frontiers in immunology, 2022-06, Vol.13, p.862752-862752

2022

Volltextzugriff (PDF)

Anti-GAD65 Antibody-Associated Autoimmune Encephalitis With Predominant Cerebellar Involvement Following Toripalimab Treatment: A Case Report of a Novel irAE of Toripalimab

Frontiers in immunology, 2022-03, Vol.13, p.850540

2022

Volltextzugriff (PDF)

Immunosensitivity mediated by downregulated AKT1-SKP2 induces anti-PD-1-associated thyroid immune injury

International immunopharmacology, 2023-08, Vol.121, p.110452-110452, Article 110452

2023

Volltextzugriff (PDF)

Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis

Frontiers in immunology, 2021-12, Vol.12, p.803410-803410

2021

Volltextzugriff (PDF)

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis

Immunotherapy, 2021-02, Vol.13 (3), p.257-270

2021

Volltextzugriff (PDF)

Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events

Frontiers in immunology, 2022-03, Vol.13, p.804597

2022

Volltextzugriff (PDF)

Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors

Cancer Immunology, Immunotherapy, 2021-08, Vol.70 (8), p.2209-2221

2021

Volltextzugriff (PDF)

Editorial: Autoimmune complications of modern cancer therapies

Frontiers in immunology, 2023, Vol.14, p.1357825-1357825

2023

Volltextzugriff (PDF)

Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition

Frontiers in immunology, 2021-01, Vol.11, p.624547

2021

Volltextzugriff (PDF)

Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer

International immunopharmacology, 2022-07, Vol.108, p.108803-108803, Article 108803

2022

Volltextzugriff (PDF)

Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis

Frontiers in immunology, 2022-06, Vol.13

2022

Volltextzugriff (PDF)

Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: a case report

Frontiers in immunology, 2023-09, Vol.14

2023

Volltextzugriff (PDF)

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis

Frontiers in immunology, 2023-02, Vol.14, p.1078838

2023

Volltextzugriff (PDF)

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

Oncoimmunology, 2019-05, Vol.8 (5), p.e1581530-e1581530

2019

Volltextzugriff (PDF)

Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody

Frontiers in immunology, 2023-11, Vol.14, p.1284301-1284301

2023

Volltextzugriff (PDF)

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Cancer Immunology, Immunotherapy, 2022-05, Vol.71 (5), p.1157-1165

2022

Volltextzugriff (PDF)

Fluctuations in serum adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis

Journal for immunotherapy of cancer, 2024-02, Vol.12 (2)

2024

Volltextzugriff (PDF)

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients

Thoracic cancer, 2020-09, Vol.11 (9), p.2406-2430

2020

Volltextzugriff (PDF)

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Cancer Immunology, Immunotherapy, 2020-11, Vol.69 (11), p.2403-2408

2020

Volltextzugriff (PDF)

Fever of unknown origin associated with immune checkpoint inhibitors

Frontiers in immunology, 2024-03, Vol.15, p.1364128-1364128

2024

Volltextzugriff (PDF)

Tissue-resident memory T cells in immune-related adverse events: friend or foe?

Oncoimmunology, 2023-12, Vol.12 (1), p.2197358-2197358

2023

Volltextzugriff (PDF)

Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer

Frontiers in immunology, 2022-09, Vol.13

2022

Volltextzugriff (PDF)

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.40-40, Article 40

2018

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(129)
Buchkapitel
(1)

Sprache

Englisch
(129)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(124)
Humans
(79)
Immunotherapy
(52)
Oncology
(46)
Immune Checkpoint Inhibitors
(45)
Immune Checkpoint Inhibitors - Adverse Effects
(40)
Immune-Related Adverse Events
(40)
Patients
(34)
Irae
(33)
Male
(33)
Immune Checkpoint Inhibitor
(32)
Melanoma
(29)
Middle Aged
(28)
Cancer Therapies
(27)
Cancer
(26)
Female
(26)
Aged
(24)
Neoplasms - Drug Therapy
(23)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Immune checkpoint receptors in autoimmunity

The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?

Elucidation of the Application of Blood Test Biomarkers to Predict Immune-Related Adverse Events in Atezolizumab-Treated NSCLC Patients Using Machine Learning Methods

Anti-GAD65 Antibody-Associated Autoimmune Encephalitis With Predominant Cerebellar Involvement Following Toripalimab Treatment: A Case Report of a Novel irAE of Toripalimab

Immunosensitivity mediated by downregulated AKT1-SKP2 induces anti-PD-1-associated thyroid immune injury

Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis

Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events

Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors

Editorial: Autoimmune complications of modern cancer therapies

Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition

Adverse and unconventional reactions related to immune checkpoint inhibitor therapy for cancer

Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis

Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: a case report

Case report: Electrocardiographic changes in pembrolizumab-induced fatal myocarditis

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibody

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Fluctuations in serum adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis

Meta‐analysis of immune‐related adverse events of immune checkpoint inhibitor therapy in cancer patients

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Fever of unknown origin associated with immune checkpoint inhibitors

Tissue-resident memory T cells in immune-related adverse events: friend or foe?

Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Aktive Filter

Suchergebnisse filtern